Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 390 followers
Latest posts
Last updated 2 days ago
Trump administration officials are at loggerheads over future of COVID vaccines: Axios
2 days ago
Some officials in the Trump administration are at odds with others who...
CHMP thumbs-up Novo's semaglutide for MASH, as Amgen gets Tavneos re-review on data integrity concerns
2 days ago
Sanofi, Novo Nordisk, UCB and others received positive opinions from Europe's Committee...
A sales turnaround for Regeneron's Eylea franchise will have to wait at least another quarter
2 days ago
For the last several quarters, declining sales of Regeneron's eye disease treatment...
Lilly rounds out quartet of new US plants with $3.5B injectable and device facility in PA
2 days ago
On Friday, Eli Lilly unveiled designs on a new, $3.5 billion manufacturing...
Quince Therapeutics on the brink as steroid-in-blood-cell fails in rare genetic disease
2 days ago
Quince Therapeutics’ novel method of delivering steroids in a patient’s own red...
Biopharma's rebound keeping pace so far
2 days ago
This week on "The Top Line," we explore biopharma's rebound, dealmaking momentum...
CDMO Vetter maps out expansion in Germany with €480M for new plant
2 days ago
The German CDMO devoted 480 million euros ($574.3 million) to the first...
Fierce Pharma Asia—AZ's $15B China investment; Boehringer, Simcere's IBD deal; Daiichi's ADC growth push
2 days ago
AstraZeneca made a big commitment to China as CEO Pascal Soriot joined...
Why human expertise still matters in AI-driven med comms
3 days ago
RTI Health Solutions experts explain how AI can help medical communications without...
Novo gets Chamber of Commerce backing in bid to bring IRA challenge to Supreme Court
3 days ago
On Wednesday, the U.S. Chamber of Commerce filed an amicus brief calling...
HER2+ Metastatic Gastroesophageal Adenocarcinoma: Why First-Line Innovation Can’t Wait
3 days ago
Outcomes for HER2+ metastatic gastroesophageal adenocarcinoma remain poor, underscoring the need for...
Hims & Hers uses another Super Bowl ad to tackle healthcare affordability
3 days ago
The minute-long ad, which debuted online Thursday ahead of its broadcast premiere...